Crispr Therapeutics AG ( ($CRSP) ) has risen by 9.03%. Read on to learn why. Crispr Therapeutics AG has seen its stock price rise by 9.03% over ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

India's GenAI infrastructure is being built, but can a public-private partnership outpace the trillion-dollar budgets of US ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $500.0 and $750.0 for Regeneron Pharmaceuticals, spanning the ...

Tenaya Therapeutics remains pre-revenues, and it’s a thinly traded microcap. Its tight cash runway is also a concern. Read ...

Credo stock is now up more than 180% so far this year, demonstrating that there are outstanding opportunities for investors ...

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.

MongoDB (NASDAQ:MDB) shows strong growth and rising relevance while appearing in discussions linked to the Nasdaq Index Fund.

Demand is soaring for CrowdStrike's cybersecurity solutions, but it might not lead to upside for its stock in 2026.

Valens Semiconductor ("Valens"), a leader in high-performance connectivity, today announced that it will host meetings with customers, analysts and investors at Consumer Electronics Show (CES) 2026 on ...